|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
MARKET FACILITATION INDEX
Trading: REDUCE @ $0.49
Signal Strength: MEDIUM
Volatility indicators highlight potential moves of a stock which can either move sharply in the updwards or downwards direction. This indicator allows stocks to be compared on a level playing field to highlight high and low volatility. Normally, falling markets are more likely to be volatile than a rising markets due to the emotion that gets tied to trading. Use volatility indicators in conjunction with other indicators to reduce exposure to false moves.
Cogstate (ASX:CGS) Currently is a confirmed Squat Day.
The Market Facilitation Index is designed for evaluation the willingness of the market to move the price. The indicators absolute values alone cannot provide any trading signals unlike its dynamics in relation to the dynamics of the volume.
Calculation: Bill Williams Market Facilitation Index:
1) Green bar - both MFI and volume are up. Increasing trading activity means market movement acceleration;
2) Blue bar - MFI indicator is up volume is down. The movement is continuing although the volume has dropped. The trend will soon be reversing;
3) Pink bar - MFI indicator is down volume is up. The slowing down movement while volume is raising may indicate a possible break through often a U-turn;
4) Brown bar - both MFI and volume are down. The market is no longer interested in the current direction and is looking for signs of a future development;
PROFILE: Cogstate (CGS.AX)
Stock Exchange: ASX
Ticker Codes: | CGS.AX | ASX:CGS |
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain injury applications primarily in Australia, the United States, and Europe. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of disease and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations. As of June 30, 2017, it had participated in approximately 1,200 academic research studies in approximately 70 indications. The Healthcare segment provides Cognigram, a system that enables regular and standardized assessment of patients to detect cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is headquartered in Melbourne, Australia.
|JHC Japara Healthcare||0.97||4.9||745,332||-1||BEARISH|
|SPL Starpharma Holdings||1.2||4.8||106,685||-1||BEARISH|
|FDV Frontier Digital Ventures||1.14||3.6||44,326||-1||BEARISH|
|SVW Seven Holdings||19.7||2.7||632,326||0||BEARISH|
|SNL Supply Network||4.17||2.7||500||-1||BEARISH|
|FRI Finbar International||0.98||2.6||320,109||-1||BEARISH|
|MVF Monash IVF||1.01||2.5||281,730||0||BEARISH|